First slide

India based pharmaceutical company Laurus Labs agreed to acquire 100% shares of Phekolong Pharmaceuticals Pty Ltd, a wholly owned subsidiary of Aspen Pharmacare, South Africa.

Details are provided below:

  • • This deal will provide access to the South African public antiretroviral (“ARV”) sector to the company.
  • Laurus Labs a research & development driven and fully integrated pharmaceutical firm
  • The Laurus Labs is manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C.

Prominent Global Investors

View all

Related News